Mentions in the Press
Highlighting Our Clients' Media Coverage
Zepbound vs. Wegovy: Which Is Better for Weight Loss? Experts Break Down New Study Results
With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy hitters to compounded varieties, each promises to help shed pounds. But a recent head-to-head trial comparing Zepbound vs. Wegovy provided new insights into their effectiveness, making the choice slightly clearer. The findings? Zepbound led to […]
Read Now
2025 predictions: Which trends are set to shape the biotech industry this year?
It is difficult these days to talk about biotech without mentioning the revolutionary role that AI is playing – and will continue to play – in the industry. When making these same predictions last year, we said that AI was likely to be a key biotech trend in 2024. This was most certainly the case, […]
Read Now
I tried the cognitive shuffling sleep technique, and now I fall asleep in three minutes
For most of my life, I slept soundly the moment my head hit the pillow. Ever since I moved countries over a year ago, things changed. Sleep didn’t come as easily. Despite feeling adequately tired by bedtime, I’d lie awake, my mind racing with worries about work or conjuring up hypothetical scenarios about my loved […]
Read Now
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
Psychedelics biotech company Enveric Biosciences completed preclinical pharmacokinetic (PK) studies for its leading drug candidate EB-003 aimed at treating depression and anxiety without causing hallucinations. EB-003 is a neuroplastic and non-hallucinogenic N, N-Dimethyltryptamine (DMT) analog drug candidate., such as ataxia or hyperthermia.
Read Now
New study reveals the popular diet proven to ‘decrease’ the risk of cognitive decline – but only in women
Wondering how you can boost your brain health? A new study has found that sticking to one popular diet can help maintain a healthy brain and “decrease” the risk of cognitive decline over the years to come.
Read Now
Top Ten Hacks For Remote Workers To Improve Their Mental Health
The focus on mental wellness at work has become increasingly urgent, especially in the context of remote work. The flexibility of remote work allows employees to design a workday that suits their needs and supports a healthy work-life balance. However, it also lacks the essential social support systems, commonly found in traditional office environments.
Read Now
5 mindfulness techniques that can help keep your home tidy and banish mess – I’m a psychotherapist and love the Doorway Pause and Three-Task Tidy
Sometimes it takes more than sheer will to get household jobs done or build good habits into your daily chores. I’m a licensed psychotherapist and know full well how the experiences that have shaped us over the course of a lifetime, including trauma, chronic pain, and anxiety can impact our capacity and motivation to do […]
Read Now
Why Having a Dog Is So Good for Your Mental Health (Scientifically Speaking)
Taking care of a dog is a big responsibility, no doubt. And yes, sometimes it can even be a little frustrating. My six-month-old Shih-Tzu, Alfie, is still convinced that Balenciaga 3XLs are the ultimate chew toy. (He’s on a real shoelace kick, so I get it.) But most every dog owner would agree that the […]
Read Now
New Study Looks at How the Brain Changes During Pregnancy and It’s Incredible
In the new study, co-author Laura Pritschet, a PhD student, and her team determined that along with a rise in estrogen and progesterone, the gray matter in the pregnant woman’s brain deteriorated over the course of her gestation, starting as early as the ninth week.1 Neuroanatomical changes observed over the course of a human pregnancy. […]
Read Now
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
Enveric Biosciences Inc, a biotechnology company specializing in neuroplastogen therapeutics for mental health conditions, has entered into a licensing agreement with MycoMedica Life Sciences. Enveric will out-license its EVM201 program, including the drug candidate EB-002 (formerly EB-373), to MycoMedica. The partnership is set to bring forward the development of EB-002, a synthetic prodrug of psilocin for […]

